CAR-T Cells in Solid Tumors: Overcoming Resistance Mechanisms for Effective Therapy
15.09.2025In a recent article published in “Der Internist” (German), LIT scientists Dr. Markus Barden, Dr. Astrid Holzinger, and Prof. Hinrich Abken comprehensively review the challenges and emerging solutions for chimeric antigen receptor (CAR) T cell therapy in solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.